These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30349220)

  • 1. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.
    Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
    Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths.
    Li Q; Larivée P; Courteau J; Couillard S; Poder TG; Carrier N; Bélanger M; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():331-341. PubMed ID: 30787603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort.
    Trudo F; Kallenbach L; Vasey J; Chung Y; Wilk A; Slipski L; O'Brien D; Strange C
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2625-2637. PubMed ID: 32063703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of disease associated with a COPD eosinophilic phenotype.
    Ortega H; Llanos JP; Lafeuille MH; Germain G; Duh MS; Bell CF; Sama SR; Hahn B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2425-2433. PubMed ID: 30147308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
    Cui Y; Zhang W; Ma Y; Zhan Z; Chen Y
    Respir Res; 2021 Nov; 22(1):301. PubMed ID: 34819051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
    Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
    J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Hegewald MJ; Horne BD; Trudo F; Kreindler JL; Chung Y; Rea S; Blagev DP
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2629-2641. PubMed ID: 33122901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H; Hahn B; Simard EP; Mu G; Hatipoğlu U
    Int J Chron Obstruct Pulmon Dis; 2019; 14():683-692. PubMed ID: 30962682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Yu S; Zhang J; Fang Q; Tong Z
    Am J Med Sci; 2021 Jul; 362(1):56-62. PubMed ID: 33617785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD.
    Citgez E; van der Palen J; van der Valk P; Kerstjens HAM; Brusse-Keizer M
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF
    Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.